USNA Usana Health Sciences PE ratio, current and historical analysis

As of Apr 2, 2025, the USNA stock has a PE ratio of 12.34. The calculation is based on the latest EPS of $2.2 and the stock price of $27.15 per share. A decrease of 18% has been observed in the PE ratio compared to its average of 15.1 of the last four quarters.

USNA PE ratio history

How has USNA's PE ratio performed in the past

The mean historical PE ratio of Usana Health Sciences over the last ten years is 17.68. The current 12.34 P/E ratio is 30% lower than the historical average. Looking back at the last ten years, USNA's PE ratio peaked in the Jun 2018 quarter at 34.42, with a price of $115.3 and an EPS of $3.35. The Mar 2020 quarter marked the lowest point at 12.76, with a price of $59.35 and an EPS of $4.65.

Today
12.34
Average
17.68
Median
16.19
Minimum
12.76
Maximum
34.42

Usana Health Sciences PE ratio by year

Maximum annual increase: 94.93% in 2013

Maximum annual decrease: -37.75% in 2011

Year PE ratio PE change Price EPS
2024 16.22 0.19% $35.69 $2.2
2023 16.19 9.54% $53.6 $3.31
2022 14.78 -15.59% $53.2 $3.6
2022 17.51 33.77% $101.2 $5.78
2021 13.09 -27.36% $77.1 $5.89
2019 18.02 -17.87% $80 $4.44
2018 21.94 -23.85% $114.96 $5.24
2017 28.81 94.93% $74.05 $2.57
2016 14.78 -13.92% $61.2 $4.14
2016 17.17 -2.61% $63.88 $3.72
2015 17.63 31.08% $51.14 $2.9
2013 13.45 94.93% $38.86 $2.89
2012 6.9 -25% $15.8 $2.29
2011 9.2 -37.75% $15.19 $1.65
2011 14.78 1.93% $21.73 $1.47

Usana Health Sciences PE ratio by quarter (TTM)

Year PE ratio PE change Price EPS
Dec 2024 16.22 21.5% $35.69 $2.2
Sep 2024 13.35 -15.29% $37.92 $2.84
Jun 2024 15.76 4.3% $45.24 $2.87
Mar 2024 15.11 -6.67% $48.5 $3.21
Dec 2023 16.19 -14.65% $53.6 $3.31
Sep 2023 18.97 -1.3% $58.61 $3.09
Jul 2023 19.22 3.61% $63.04 $3.28
Apr 2023 18.55 25.51% $62.9 $3.39
Dec 2022 14.78 5.5% $53.2 $3.6
Oct 2022 14.01 -14.26% $56.05 $4
Jul 2022 16.34 12.85% $75 $4.59
Apr 2022 14.48 -17.3% $79.33 $5.48
Jan 2022 17.51 23.66% $101.2 $5.78
Oct 2021 14.16 -7.21% $93.58 $6.61
Jul 2021 15.26 -5.69% $102.12 $6.69

USNA average PE ratio chart

What is the average PE ratio of USNA for the past years

The current PE ratio of USNA is lower than its 3, 5 and 10-year averages.

3-year avg
16.23
5-year avg
15.61
10-year avg
17.68
15-year avg
15.93

USNA PE vs peers

What is USNA's PE ratio compared to its peers

USNA's PE ratio stands lower than its peer stocks IPAR and NATR, but it is higher than HLF's and MTEX's. Usana Health Sciences is currently trading at a lower PE ratio (12.34) than its peers average of 15.6.

Stock name PE ratio Market cap
HLF Herbalife Nutrition Ltd 3.49 $893.57M
MTEX Mannatech Inc 6.38 $16.01M
USNA Usana Health Sciences Inc 12.34 $513.26M
IPAR Inter Parfums Inc 22.32 $3.68B
NATR Natures Sunshine Products Inc 30.22 $229.01M
NUS Nu Skin Enterprises Inc N/A $354.52M
PRPH ProPhase Labs Inc N/A $16.33M

Frequently asked questions

What is Usana Health Sciences's PE ratio?

The price to earnings ratio for USNA stock as of Apr 2, 2025, stands at 12.34.

What is the 3-year average PE ratio for Usana Health Sciences (USNA)?

The average PE ratio for USNA stock over the past 3 years is 16.23.

What is the 5-year average PE ratio for Usana Health Sciences (USNA)?

The average PE ratio for USNA stock over the past 5 years is 15.61.

What is the highest PE ratio for USNA?

Over the last ten years, the Jun 2018 quarter recorded the highest quarterly PE ratio at 34.42.

How does the current PE ratio for USNA compare to its historical average?

USNA's current price to earnings ratio is 30% below its 10-year historical average.

How is USNA's PE ratio calculated (Usana Health Sciences PE ratio formula)?

To determine the P/E ratio, divide the latest stock price by the TTM earnings per share (EPS). As of today (Apr 2, 2025), Usana Health Sciences's share price is $27.15. The company's earnings per share for the trailing twelve months (TTM) ending Dec 2024 is $2.2. Therefore, Usana Health Sciences's PE ratio for today is 12.34. PE RATIO(12.34) = STOCK PRICE($27.15) / TTM EPS($2.2)

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.